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Chronotropic Incompetence in Heart Failure
The relationship between heart rate (HR) during exercise and
exercise capacity in patients with heart failure due to left ventric-
ular systolic dysfunction remains unclear. The accepted diagnostic
criterion for chronotropic incompetence (CI), a maximum age-
predicted heart rate (MA-PHR) 85%, is seen in 50% of patients
with severe heart failure on contemporary medical therapy (1).
Whether the lesser HR rise is the cause of the exercise impairment
is less certain: as HR increases as a function of exercise load, it is
inevitable that HR at peak exercise will be lower in subjects with
worse exercise capacity.
Tse et al. (2) are to be congratulated in trying to explore these
issues in their study of patients with cardiac resynchronization
devices. However, some important issues were raised by their
suggestion that rate-adaptive pacing might be more widely used in
patients with resynchronization devices. In patients with the most
severe CI, defined as failure to reach 70% of age-predicted
maximum HR (n  11), Tse et al. were able to demonstrate an
increase in exercise capacity with rate-adaptive pacing. There are
no published data on the incidence of their chosen value of 70%,
although it was seen in 28% of patients in our dataset (1).
At first sight, this seems a useful incremental benefit. However,
using the more widely accepted definition of failure to achieve 85%
of age-predicted maximal HR (3), there was no benefit of rate
response pacing. In fact, in one-third of patients with less severe CI
(MA-PHR 70% to 85%), there was a reduction in exercise capacity
with rate response pacing.
Although CI in chronic heart failure (CHF) patients not taking
beta-blockers predicts a worse prognosis (1), lower HRs at rest are
associated with improved outcomes in beta-blocker–treated indi-
viduals (4). We have also previously demonstrated that HR
lowering by aggressive use of beta-blockers does not reduce
exercise capacity (1,5). Hence, the issue of CI in patients with
severe CHF is not resolved. Furthermore, the long-term effects of
rate response pacing and the consequent higher average HR on
mortality and left ventricular function are unknown. It is too early
to suggest that patients undergoing CRT should have their device’s
rate response function active.
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We thank Drs. Witte and Clark for their interest in our study (1).
We agree with their comment that there is no established
diagnostic criterion for chronotropic incompetence (CI) for pa-
tients with heart failure (HF). The commonly used definition of
the age-predicted heart rate (HR) to diagnose CI is traditionally
employed for patients with ischemic heart disease. Despite the
wide application of rate-adaptive pacing, there is also no estab-
lished definition of CI for pacemaker patients (2). From a pacing
standpoint, the detection of CI is clinically relevant only when
there is a functional improvement associated with rate-adaptive
pacing. Prior studies have shown that HF patients with CI have
lower peak oxygen consumption as compared with those without
CI (3). Our data demonstrate that the conventional definition of
CI is not applicable to patients with HF implanted with cardiac
resynchronization therapy (CRT). Indeed, rate-adaptive pacing
was found to be beneficial only in those patients with severe CI
who failed to achieve 70% of age-predicted HR, and potentially
harmful to patients with mild CI based on the conventional
definition. Furthermore, the incidence of CI in HF patients
implanted with CRT appears to be higher than for those reported
in the general HF population (4). We have evaluated a total of 28
patients and have enrolled 20 patients (71%) with age-predicted
HR 85% for this study. This is likely because the current CRT
patients have more severe HF (class III to IV) and advanced
conduction system abnormalities as compared with the general HF
population.
As mentioned by Drs. Witte and Clark, a lower HR at rest
predicts better outcome in patients treated with a beta-blocker.
The use of rate-adaptive pacing only increases HR during exercise,
but not the resting HR, and the increase in 24-h HR due to
rate-adaptive pacing is minimal. In fact, the use of rate-adaptive
pacing can alleviate the CI to allow more aggressive use of
beta-blockers. Consistent with the findings in their recent studies
(4), we have shown that the percentage of HR changes during
exercise positively correlated with peak oxygen consumption (1).
We believe that our data have demonstrated that rate-adaptive
pacing is complementary to the use of CRT and optimal medical
therapy, including beta-blocker, to improve exercise capacity in
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HF patients, and appropriate rate-adaptive pacing should be
considered in patients in whom CRT response is suboptimal
owing to concurrent CI.
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Role of Septal to Posterior Wall Motion
Delay in Cardiac Resynchronization Therapy
In a recent issue of the Journal, Marcus et al. (1) report that septal
to posterior wall motion delay (SPWMD) fails to predict reverse
remodeling or clinical improvement in patients having heart failure
and treated with cardiac resynchronization therapy (CRT), and
they conclude that SPWMD should not be used to guide the
selection of candidates for CRT. Because these findings and
recommendations are contrary to our published reports and have
significant clinical implications, it is important for your readership
to understand that the method used to determine SPWMD in
their study is not the one we demonstrated previously to predict
both reverse remodeling and prognosis (2,3). Apart from the
limitations and biases inherent in retrospective analyses, we will
focus on the differences between the two methods, the one we and
others (4–6) have successfully used and the present one, and which
we believe led to the disparity in outcomes. We believe that the key
to the prognostic value of our method is the measuring of the
SPWMD in the short axis. The rationale of measuring the
SPWMD by using the short axis view at the level of the papillary
muscles, and is related to histological and anatomic relationships
not shared with the longitudinal axis.
Specifically, the factors determining the measure of the delay
between the septum and the posterior wall obtained by using the
two methods differ in several ways:
1. The direction of the myocardial fibers differs between the basal
and midventricular levels. At the level of the midventricle, the
fibers have a circular course.
2. The sequence of myocardial activation differs between the basal
and midventricle levels in the presence of left bundle branch
block (7), is variable (8), and cannot be predicted by the
electrocardiogram. In particular, the ventricular conduction
delay resulting from an area of conduction failure (due to
scarred tissue or functional block) or from slow but homoge-
neous myocardial propagation gives rise to an activation of the
basal segments of the left ventricle that is different from that of
mid left ventricular level. This different pattern of activation
might be responsible for the fragmented mechanical activity
that is seen more frequently at the level of the basal septum
than at the mid left ventricular level.
3. The long axis evaluation of dyssynchrony is limited by the
inherent difficulties to define accurately which area (i.e., lateral,
posterolateral) is visualized and obtain a perpendicular to the
long axis of the ventricle view (this is the case of both images
shown in the study by Marcus et al. [1] in which the
midseptum is compared to the basal free wall).
4. Basal segments being tied to fibrous skeleton of the heart
and their movements are strongly influenced but in variable and
unpredictable ways by the movements of the aortic root and
mitral annulus. These influences could cause an irregular
contraction of the septal wall, thus leading to a more difficult
calculation of maximum septal displacement and to a less
reproducible measure.
We hope that this explanation helps in understanding that taking
the measurement in another way cannot a priori be expected to yield
equivalent physiological or clinically relevant information; there-
fore, the parameter used by Marcus et al. (1), although given the
same name as ours, is not the same as ours and that the conclusions
drawn by their study cannot be applied to the SPWMD parameter
we have described.
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